Document is current
Any future updates will be listed below
-
Authors
Adrean, Sean D. https://orcid.org/0000-0001-6004-0643
Knight, Darren
Chaili, Siyang
Ramkumar, Hema L.
Pirouz, Ash
Grant, Scott
-
Funding
Funding for this research was provided by:
Regeneron Pharmaceuticals (IIS VGFTe-AMD-17104)
- License Information
-
More Information
Article History
Received: 22 May 2021
Accepted: 30 January 2022
First Online: 10 February 2022
Declarations
:
: This retrospective study received IRB approval from IRBco. (2017-0050-RCOC) and the study adhered to the tenets set forth in the declaration of Helsinki. All of the information and data collected was in accordance with the Health Insurance Portability and Accountability Act (HIPAA).
: Not applicable.
: SA, HR, AP and SG: Are researchers with Adverum, Allergan, Apellis, Chengdu Kanghong, Clearside Biomedical, Genentech/Roche, Gemini Therapeutics, Graybug Vision, Gyroscope, Iveric Bio, Kodiak, Opthea, Regeneron, and REGENXBIO. DK and SC have no competing interests. SA is a consultant with Adverum and received grant support from Regeneron.
